The National Institute for Health and Care Excellence (NICE) is proposing placing more emphasis on “real world evidence” […]
Category: Uncategorized
Conclusions made by a group of experts from academia and industry
Approval is based on results from phase III THALES trial
Industry bodies respond to Specialised Committee outcome
New approval marks third indication for an Opdivo plus Yervoy-based regimen in the EU
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT